SPHERA FUNDS MANAGEMENT LTD. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,125 filers reported holding NOVARTIS A G in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$6,111,600
+0.9%
60,0000.0%1.11%
+17.8%
Q2 2023$6,054,600
+9.7%
60,0000.0%0.94%
+2.5%
Q1 2023$5,520,000
-89.4%
60,000
-89.1%
0.92%
-80.0%
Q4 2020$51,842,000
+109.2%
549,000
+92.6%
4.60%
+89.0%
Q3 2020$24,784,000
+57.6%
285,000
+58.3%
2.44%
+64.7%
Q2 2020$15,721,000
+36.2%
180,000
+28.6%
1.48%
+2.4%
Q1 2020$11,543,000
-39.0%
140,000
-30.0%
1.44%
-7.5%
Q4 2019$18,938,000
+97.0%
200,000
+100.0%
1.56%
+77.8%
Q1 2019$9,614,000
-39.8%
100,000
-50.0%
0.88%
-67.6%
Q2 2017$15,960,000
-15.8%
200,000
-21.6%
2.71%
-26.8%
Q1 2017$18,959,000
+1124.0%
255,000
+1316.7%
3.71%
+1532.6%
Q4 2015$1,549,000
-15.7%
18,000
-10.0%
0.23%
-3.4%
Q3 2015$1,838,000
-81.3%
20,000
-80.0%
0.24%
-75.6%
Q2 2015$9,834,000
-0.3%
100,0000.0%0.96%
-6.2%
Q1 2015$9,861,000
-75.9%
100,000
-77.3%
1.03%
-85.2%
Q4 2014$40,846,000
-9.6%
439,621
-8.2%
6.96%
+24.7%
Q3 2014$45,179,000
-6.4%
478,921
-10.2%
5.58%
-53.1%
Q2 2014$48,272,000
+6.2%
533,100
-0.4%
11.90%
+14.7%
Q1 2014$45,435,000
+1784.5%
535,100
+1683.7%
10.37%
+1443.5%
Q4 2013$2,411,00030,0000.67%
Other shareholders
NOVARTIS A G shareholders Q2 2020
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders